We are pleased to serve as joint bookrunner for ANI Pharmaceuticals, Inc.’s $275 Million Rule 144A Offering of Convertible Senior Notes. Learn more about us and see all of our transactions online at https://lnkd.in/eGZsdSw
Leerink Partners’ Post
More Relevant Posts
-
Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. Here are some examples of how pharmaceutical companies can use sponsorships to engage communities: https://lnkd.in/dBNPt8KM
To view or add a comment, sign in
-
Use LS Retail for your pharmaceutical business, LS Retail is the one-stop solution for all your pharmaceutical needs. LS Retail, an Aptos Company #RetailSolutions #LsRetail #BusinessGrowth #ebt
To view or add a comment, sign in
-
Discover the ultimate guide to selecting the perfect Pharma Franchise Company! Unveil expert tips and crucial factors to ensure a successful partnership in the pharmaceutical industry. Read our comprehensive blog now and make an informed decision for your business growth. https://lnkd.in/gR2FdfbA
To view or add a comment, sign in
-
In our latest report "How Business Strength Varies Across Top Branded Pharmaceutical Companies (2024 Update)" we summarise the key quantitative measures we consider when assessing the businesses strength of the largest pharmaceutical companies we rate, how those metrics varied across these peers in 2023, and how this influences our view. Read more here: https://okt.to/EvQSpP
To view or add a comment, sign in
-
Sensex Today | Stock Market LIVE Updates: B&K Securities has maintained its ‘Buy’ rating with Target Price of Rs. 770 (CMP- Rs. 622) for Suven Pharmaceuticals as it expect revenue of the company to double at combined sales (Suven + Cohance) over the next four-five years. The company remains top mid-cap pick in brokerage firm’s universe.
To view or add a comment, sign in
-
https://bit.ly/4c9bOrW Read our blog series, “Rise with the Waves: State of the Global Policy Landscape” which focuses on policy updates in Germany, Italy, Canada, France and the UK and the impact for pharmaceutical manufacturers.
To view or add a comment, sign in
-
Navigating the #IRA will differ for selected products compared to their competitors. Learn key considerations for both categories of products to stay oriented in these changes in our latest blog.
From price adjustments to contracting strategies, the Inflation Reduction Act will have a wide range of direct and indirect impacts on pharmaceutical sponsors and manufacturers. In our latest blog, we outline considerations for selected and non-selected drugs to help sponsors understand and adapt to these changes. Learn more here: https://ow.ly/XMRr50TmL0n
To view or add a comment, sign in
-
Navigating the #IRA will differ for selected products compared to their competitors. Learn key considerations for both categories of products to stay oriented in these changes in our latest blog.
From price adjustments to contracting strategies, the Inflation Reduction Act will have a wide range of direct and indirect impacts on pharmaceutical sponsors and manufacturers. In our latest blog, we outline considerations for selected and non-selected drugs to help sponsors understand and adapt to these changes. Learn more here: https://ow.ly/XMRr50TmL0n
To view or add a comment, sign in
-
From price adjustments to contracting strategies, the Inflation Reduction Act will have a wide range of direct and indirect impacts on pharmaceutical sponsors and manufacturers. In our latest blog, we outline considerations for selected and non-selected drugs to help sponsors understand and adapt to these changes. Learn more here: https://ow.ly/XMRr50TmL0n
To view or add a comment, sign in
-
Navigating the #IRA will differ for selected products compared to their competitors. Learn key considerations for both categories of products to stay oriented in these changes in our latest blog.
From price adjustments to contracting strategies, the Inflation Reduction Act will have a wide range of direct and indirect impacts on pharmaceutical sponsors and manufacturers. In our latest blog, we outline considerations for selected and non-selected drugs to help sponsors understand and adapt to these changes. Learn more here: https://ow.ly/XMRr50TmL0n
To view or add a comment, sign in
17,729 followers